Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Confirm Safety and Effectiveness of RADIESSE® Injectable Implant for the Correction of Moderate to Severe Nasolabial Folds
Sponsor: Merz North America, Inc.
Summary
The purpose of this study is to confirm the long-term safety, effectiveness, and degradation profile of RADIESSE® Injectable Implant for the correction of moderate to severe nasolabial folds (NLFs) in Chinese adults. Eligible participants will receive treatment with RADIESSE® Injectable Implant in both NLFs and may receive an optional touch-up treatment at Month 1 at investigator's discretion. Participants will be followed for up to 24 months after last treatment.
Official title: A Prospective, Open-Label, Multicenter, Post-Market Clinical Follow-Up Study to Confirm the Long-term Safety and Effectiveness of RADIESSE® Injectable Implant for the Correction of Moderate to Severe Nasolabial Folds
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
163
Start Date
2026-10-27
Completion Date
2029-02
Last Updated
2026-10-29
Healthy Volunteers
No
Conditions
Interventions
Subdermal Implant
Participants will receive treatment with RADIESSE® Injectable Implant.
Locations (8)
Merz Investigative Site
Beijing, China
Merz Investigative Site
Changde, China
Merz Investigative Site
Chengdu, China
Merz Investigative Site
Gaozhou, China
Merz Investigative Site
Hangzhou, China
Merz Investigative Site
Nanjing, China
Merz Investigative Site
Xianyang, China
Merz Investigative Site
Yibin, China